AMATO, Rosario
 Distribuzione geografica
Continente #
NA - Nord America 615
EU - Europa 224
AS - Asia 8
Continente sconosciuto - Info sul continente non disponibili 6
SA - Sud America 3
OC - Oceania 1
Totale 857
Nazione #
US - Stati Uniti d'America 601
IT - Italia 139
SE - Svezia 39
GB - Regno Unito 31
CA - Canada 14
DE - Germania 5
EU - Europa 5
IN - India 5
NL - Olanda 3
CL - Cile 2
FI - Finlandia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AT - Austria 1
CN - Cina 1
ES - Italia 1
FR - Francia 1
IL - Israele 1
NZ - Nuova Zelanda 1
PE - Perù 1
PL - Polonia 1
TW - Taiwan 1
UA - Ucraina 1
Totale 857
Città #
Chandler 167
Catanzaro 39
Princeton 37
Lawrence 36
Ashburn 30
London 30
Chicago 22
Wilmington 19
Des Moines 18
Seattle 16
Ottawa 11
Norwalk 10
Genova 6
Florence 5
Campi Salentina 4
Falls Church 4
Grottaglie 4
Redmond 4
Hanover 3
Lurate Caccivio 3
Napoli 3
Siena 3
Arcene 2
Castrolibero 2
Helsinki 2
Leawood 2
Naples 2
Pune 2
Redwood City 2
Rome 2
Sermoneta 2
Villongo 2
West Jordan 2
Aachen 1
Albino 1
Amsterdam 1
Apo 1
Bhavnagar 1
Borås 1
Clearwater 1
Gaithersburg 1
Isola di Capo Rizzuto 1
La Canada Flintridge 1
Laval 1
Lima 1
Los Angeles 1
Madrid 1
Nandyāl 1
Phoenix 1
Rende 1
Rotterdam 1
Roubaix 1
Saint Louis 1
Sezze 1
Suzhou 1
Taichung 1
Toronto 1
Troina 1
Turin 1
Vancouver 1
Varese 1
Washington 1
Wellington 1
Totale 526
Nome #
Alternative splicing regulation in tumour cells of gene encoding the tyrosine phosphatase PTPRJ 40
Deregulation of SGK1 in Ulcerative Colitis: A Paradoxical Relationship Between Immune Cells and Colonic Epithelial Cells. 38
Preclinical model in HCC: the SGK1 kinase inhibitor SI113 blocks tumor progression in vitro and in vivo and synergizes with radiotherapy. 37
In Preclinical Model of Ovarian Cancer, the SGK1 Inhibitor SI113 Counteracts the Development of Paclitaxel Resistance and Restores Drug Sensitivity 35
The receptor protein tyrosine phosphatase PTPRJ negatively modulates the CD98hc oncoprotein in lung cancer cells. 33
The SGK1 Kinase Inhibitor SI113 Sensitizes Theranostic Effects of the 64CuCl2 in Human Glioblastoma Multiforme Cells 32
The Emerging Role of SGK1 (Serum- and Glucocorticoid-Regulated Kinase 1) in Major Depressive Disorder: Hypothesis and Mechanisms 31
A familial form of epidermolysis bullosa simplex associated with a pathogenic variant in krt5 31
SGK1, the serum- and glucocorticoid-regulated kinase, modulates the response to taxanes by regulating the GTPase RAN and its partners in colon carcinoma cells. 28
In silico identification and biological evaluation of novel selective serum/glucocorticoid-inducible kinase 1 inhibitors based on the pyrazolo-pyrimidine scaffold 28
The human asparaginase enzyme (ASPG) inhibits growth in leukemic cells 28
SI113, a Specific Inhibitor of the Sgk1 Kinase Activity that Counteracts Cancer Cell Proliferation 26
Germline Testing in a Cohort of Patients at High Risk of Hereditary Cancer Predisposition Syndromes: First Two-Year Results from South Italy 25
Determination of SGK1 mRNA in non-small cell lung cancer samples underlines high expression in squamous cell carcinomas. 25
SGK1 affects RAN/RANBP1/RANGAP1 via SP1 to play a critical role in pre-miRNA nuclear export: a new route of epigenomic regulation 25
Identification of a new mutation in the gene coding for hairless protein responsible for alopecia universalis: The importance of direct gene sequencing 25
Pyrrolo[2,3-d]pyrimidines active as Btk inhibitors 25
Indole and 2,4-Thiazolidinedione conjugates as potential anticancer modulators 24
Deregulation of SGK1 in Ulcerative Colitis: a paradoxical relationship between immune cells and colonic epithelial cells 23
Meccanismi genetici e molecolari della Sindrome X metabolica 23
Data on the effects of low iron diet on serum lipid profile in HCV transgenic mouse model 23
RANBP1 (RAN Binding Protein 1): The Missing Genetic Piece in Cancer Pathophysiology and Other Complex Diseases 22
60 kDa Lysophospholipase, a New Sgk1 MolecularnPartner Involved in the Regulation of ENaC 22
Review about the multi-target profile of resveratrol and its implication in the SGK1 inhibition 22
Pathophysiology of the insulin receptor signal transduction 21
IL-2 signals through Sgk1 and inhibits proliferation and apoptosis in kidney cancer cells 21
60kDa lysophospholipase, a new Sgk1 molecular partner involved in the regulation of ENaC 21
Sgk1 enhances RANBP1 transcript levels and decreases taxol sensitivity in RKO colon carcinoma cells. 20
Sgk1 activates MDM2-dependent p53 degradation and affects cell proliferation, survival, and differentiation 19
Sgk1 promotes cell proliferation, survival and epithelial dedifferentiation by activating HDM2 dependent p53 degradation 17
Th17-Gene Expression Profile in Patients with Chronic Venous Disease and Venous Ulcers: Genetic Modulations and Preliminary Clinical Evidence 13
SGK1 (serum/glucocorticoid regulated kinase 1) 13
SI113, a SGK1 inhibitor, potentiates the effects of radiotherapy, modulates the response to oxidative stress and induces cytotoxic autophagy in human glioblastoma multiforme cells. 13
Kinase Inhibitors in Genetic Diseases 10
The kinase inhibitor SI113 induces autophagy and synergizes with quinacrine in hindering the growth of human glioblastoma multiforme cells. 9
Serum and glucocorticoid-regulated kinase Sgk1 inhibits insulin-dependent activation of phosphomannomutase 2 in transfected COS-7 cells 8
The small molecule SI113 synergizes with mitotic spindle poisons in arresting the growth of human glioblastoma multiforme 8
SGK1, the New Player in the Game of Resistance: Chemo-Radio Molecular Target and Strategy for Inhibition 8
The small molecule SI113 hinders epithelial-to-mesenchymal transition and subverts cytoskeletal organization in human cancer cells. 8
RANBP1 regulates the SGK1-dependent Th17 pathological differentiation: nuclear export hypothesis 7
RANBP1, a member of the nuclear-cytoplasmic trafficking-regulator complex, is the terminal-striking point of the SGK1-dependent Th17+ pathological differentiation 7
RFX-1, a putative alpha Adducin interacting protein in a human kidney library 6
Relative Resistance of SGK1 Knockout Mice Against Chemical Carcinogenesis 5
Metabolic drives affecting Th17/Treg gene expression changes and differentiation: impact on immune‐microenvironment regulation 3
The SGK1 Inhibitor SI113 Induces Autophagy, Apoptosis and Endoplasmic Reticulum Stress in Endometrial Cancer Cells 3
The small molecule SI113 hinders epithelial-to-mesenchymal transition and subverts cytoskeletal organization in human cancer cells 1
Totale 912
Categoria #
all - tutte 9.747
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.747


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202036 0 0 0 0 5 1 5 3 0 1 6 15
2020/202198 4 1 0 7 11 23 10 0 21 3 8 10
2021/2022138 2 0 2 39 3 12 5 16 22 17 20 0
2022/2023433 73 47 23 21 47 34 3 43 81 27 29 5
2023/2024207 38 29 11 18 15 58 2 24 5 7 0 0
Totale 912